Breath biomarkers associated with nontuberculosis mycobacteria disease status in persons with cystic fibrosis: a pilot study
Open Access
- 13 May 2022
- journal article
- research article
- Published by IOP Publishing in Journal of Breath Research
- Vol. 16 (3) , 031001
Abstract
Pulmonary infections caused by mycobacteria cause significant mortality and morbidity in the human population. Diagnosing mycobacterial infections is challenging. An infection can lead to active disease or remain indolent with little clinical consequence. In patients with pulmonary nontuberculosis mycobacteria (PNTM) identification of infection and diagnosis of disease can take months to years. Our previous studies showed the potential diagnostic power of volatile molecules in the exhaled breath samples to detect active pulmonary M. tuberculosis infection. Herein, we demonstrate the ability to detect the disease status of PNTM in the breath of persons with cystic fibrosis (PwCF). We putatively identified 17 volatile molecules that could discriminate between active-NTM disease (n = 6), indolent patients (n = 3), and those patients who have never cultured an NTM (n = 2). The results suggest that further confirmation of the breath biomarkers as a non-invasive and culture-independent tool for diagnosis of NTM disease in a larger cohort of PwCF is warrantedKeywords
Funding Information
- National Institutes of Health (R01 HL146228-01)
This publication has 47 references indexed in Scilit:
- Pulmonary Nontuberculous Mycobacterial Disease, Ontario, Canada, 1998–2010Emerging Infectious Diseases, 2013
- Volatile Emissions from Mycobacterium avium subsp. paratuberculosis Mirror Bacterial Growth and Enable Distinction of Different StrainsPLOS ONE, 2013
- Point-of-care breath test for biomarkers of active pulmonary tuberculosisTuberculosis, 2012
- Breath biomarkers of active pulmonary tuberculosisTuberculosis, 2010
- Volatile biomarkers of pulmonary tuberculosis in the breathTuberculosis, 2007
- Analysis of human breath samples with a multi-bed sorption trap and comprehensive two-dimensional gas chromatography (GC×GC)Journal of Chromatography B, 2006
- Value of the Chlorhexidine Decontamination Method for Recovery of Nontuberculous Mycobacteria from Sputum Samples of Patients with Cystic FibrosisJournal of Clinical Microbiology, 2006
- Comparison of NaOH-N-acetyl cysteine and sulfuric acid decontamination methods for recovery of mycobacteria from clinical specimensJournal of Microbiological Methods, 2005
- Improved Decontamination Method for Recovering Mycobacteria from Patients with Cystic FibrosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Alcohol breath tests: Criterion times for avoiding contamination by “mouth alcohol”Behavior Research Methods, 1978